Report Updates Evidence on Pharmacotherapy for Adults With Alcohol Use Disorder
According to an updated systematic review from AHRQ’s Effective Health Care Program, decisions about medication-assisted treatment for alcohol use disorder (AUD), including the use of drugs such as naltrexone or acamprosate, should be made collaboratively between patients and clinicians with considerations for desired outcomes, tolerance of side effects, contraindications, and the potential to adhere to the medication regimen.
The report, which updates a 2014 systematic review, recognizes that the literature on medications for AUD has grown substantially. AHRQ expects that this updated systematic review from will be helpful to health plans, care providers, government programs, and healthcare systems.
Select to access the report, which includes key findings on the benefits and harms of several medications.